ES2045052T3 - Antagonistas de leucotrienos ltd4 y ltb4. - Google Patents

Antagonistas de leucotrienos ltd4 y ltb4.

Info

Publication number
ES2045052T3
ES2045052T3 ES88115671T ES88115671T ES2045052T3 ES 2045052 T3 ES2045052 T3 ES 2045052T3 ES 88115671 T ES88115671 T ES 88115671T ES 88115671 T ES88115671 T ES 88115671T ES 2045052 T3 ES2045052 T3 ES 2045052T3
Authority
ES
Spain
Prior art keywords
low
ltd4
antagonists
alkyl
fenilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88115671T
Other languages
English (en)
Spanish (es)
Inventor
James Ronald Deason
Michael Allan Stealey
Richard Mathias Weier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/100,685 external-priority patent/US4808729A/en
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2045052T3 publication Critical patent/ES2045052T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES88115671T 1987-09-24 1988-09-23 Antagonistas de leucotrienos ltd4 y ltb4. Expired - Lifetime ES2045052T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/100,685 US4808729A (en) 1987-09-24 1987-09-24 Leukotriene LTD4 and LTB4 antagonists
US07/241,265 US4923891A (en) 1987-09-24 1988-09-09 Leukotriene LTD4 and LTB4 antagonists

Publications (1)

Publication Number Publication Date
ES2045052T3 true ES2045052T3 (es) 1994-01-16

Family

ID=26797440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88115671T Expired - Lifetime ES2045052T3 (es) 1987-09-24 1988-09-23 Antagonistas de leucotrienos ltd4 y ltb4.

Country Status (14)

Country Link
US (1) US4923891A (enExample)
EP (1) EP0308956B1 (enExample)
JP (1) JPH01132577A (enExample)
KR (1) KR890005082A (enExample)
AU (1) AU610246B2 (enExample)
DE (1) DE3878806T2 (enExample)
DK (1) DK530888A (enExample)
ES (1) ES2045052T3 (enExample)
FI (1) FI884377A7 (enExample)
GR (1) GR3007858T3 (enExample)
IL (1) IL87800A (enExample)
NO (1) NO171412C (enExample)
NZ (1) NZ226318A (enExample)
PT (1) PT88580B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5579409A (en) * 1991-09-27 1996-11-26 E. I. Du Pont De Nemours And Company Methods for determining the exterior points of an object in a background
EP0833664A1 (en) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
ES2243978T3 (es) * 1996-02-13 2005-12-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de la ciclooxigenasa-2 y un antagonista del receptor de leucotrieno b4.
DE69911020T2 (de) * 1999-10-06 2004-07-08 Dainippon Ink And Chemicals, Inc. 4-Methylen-1,3-dioxolane mit funktionellen Gruppen
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
CN103396393B (zh) * 2005-11-22 2016-03-02 塞格提斯有限公司 甘油乙酰丙酸酯缩酮及其用途
CA2668294C (en) * 2007-10-09 2010-12-07 Segetis, Inc. Method of making ketals and acetals
CN102239156B (zh) 2008-09-25 2014-10-15 塞格提斯有限公司 缩酮酯衍生物
BRPI1013943B1 (pt) 2009-06-22 2020-03-17 Segetis, Inc. Composto, método para sintetizar o mesmo, composição e composição lubrificante
CN102883705A (zh) 2010-05-10 2013-01-16 赛格提斯公司 含有烷基缩酮酯的个人护理制剂以及制造方法
AU2011285715B2 (en) 2010-08-03 2016-04-21 Gfbiochemicals Limited Methods for the manufacture of acetals and ketals, and the acetals and ketals produced thereby
US9074065B2 (en) 2010-08-12 2015-07-07 Segetis, Inc. Latex coating compositions including carboxy ester ketal coalescents, methods of manufacture, and uses thereof
CA2803389C (en) 2010-08-12 2016-10-11 Segetis, Inc. Carboxy ester ketal removal compositions, methods of manufacture, and uses thereof
US8632612B2 (en) 2010-09-07 2014-01-21 Segetis, Inc. Compositions for dyeing keratin fibers
CN103097604A (zh) 2010-09-13 2013-05-08 赛格提斯有限公司 织物软化剂组合物及其制造方法
KR20130131323A (ko) 2010-10-18 2013-12-03 세게티스, 인코포레이티드. 카복시 에스터 케탈을 포함하는 수희석성 코팅 조성물, 그리고 그의 제조방법 및 용도
US9458414B2 (en) 2012-09-21 2016-10-04 Gfbiochemicals Limited Cleaning, surfactant, and personal care compositions
BR112015012471B1 (pt) 2012-11-29 2020-05-19 Segetis Inc cetais de carbóxi éster , métodos de fabricação e uso dos mesmos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2839445A (en) * 1954-01-11 1958-06-17 Du Pont Fungicidal and anti-oxidant compositions comprising 1, 3-dithiolanes
FR1448340A (fr) * 1964-07-09 1966-08-05 Boehringer Sohn Ingelheim Procédé pour fabriquer des nouveaux 1, 3-dioxolanes
FR1445013A (fr) * 1964-07-09 1966-07-08 Thomae Gmbh Dr K Procédé pour fabriquer des nouveaux acides dioxolano-2-carboxyliques
FR4493M (enExample) * 1964-07-09 1966-10-10
GB1427918A (en) * 1972-05-26 1976-03-10 Shell Int Research Herbicidal glycerol acetals
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
AU2274188A (en) 1989-04-06
EP0308956A3 (en) 1990-06-13
NO171412C (no) 1993-03-10
FI884377A0 (fi) 1988-09-23
IL87800A (en) 1992-12-01
US4923891A (en) 1990-05-08
PT88580B (pt) 1992-11-30
FI884377L (fi) 1989-03-25
EP0308956B1 (en) 1993-03-03
NZ226318A (en) 1991-08-27
JPH01132577A (ja) 1989-05-25
DK530888A (da) 1989-03-25
FI884377A7 (fi) 1989-03-25
EP0308956A2 (en) 1989-03-29
NO884223L (no) 1989-03-28
PT88580A (pt) 1988-10-01
KR890005082A (ko) 1989-05-11
GR3007858T3 (enExample) 1993-08-31
DK530888D0 (da) 1988-09-23
AU610246B2 (en) 1991-05-16
DE3878806T2 (de) 1993-07-01
NO171412B (no) 1992-11-30
NO884223D0 (no) 1988-09-23
IL87800A0 (en) 1989-03-31
DE3878806D1 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
ES2045052T3 (es) Antagonistas de leucotrienos ltd4 y ltb4.
ES2117034T3 (es) Composicion para la limpieza de vidrio.
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2093650T3 (es) Una solucion farmaceutica que comprende derivados de fk506.
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
ES2065133T3 (es) Derivados de piperazina.
IT1295694B1 (it) Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
ES2002254T3 (es) Nuevos 5-alcoxi-2,4-diamino-alquilbenzenos asi como tintes para el cabello con 5-alcoxi-2,4-diamino-alquil-benzenos.
ES2099047T1 (es) Compuesto de sales opticamente puras de piridinilmetil, sulfinil, bencimidazol.
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2069921T3 (es) Antagonistas del nmda.
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
ES2063513T3 (es) Nuevos derivados del oxazol, su preparacion y las composiciones farmaceuticas que les contienen.
ES2032217T3 (es) Nuevos derivados n-(23-vinblastinoil del acido 1-amino-metilfosfonico, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9305523A (es) Composiciones quimoterapeuticas mejoradas frente a infecciones microbianas en peces, la reparacion y uso de las mismas.
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2058264T3 (es) Sulfonildecahidro-8h-isoquino(2,1-g)(1,6)naftiridinas, isomeros opticos de las mismas y compuestos afines.
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9203234A (es) Derivados de 5-halovinil-2-desoxiuridina y composiciones farmaceuticas que los contienen.
MX12167A (es) Una composicion farmaceutica de los derivados de 1,2-bencisoxasola y 1,2-bencixotiazola y procedimiento para su preparacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 308956

Country of ref document: ES